| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $110.8M | -18.3% |
| Cost of Revenue | $77.9M | -6.2% |
| Gross Profit | $32.9M | -37.4% |
| R&D Expense | $18.9M | +16.4% |
| SG&A Expense | $29.8M | +12.3% |
| Operating Income | -$11.3M | -258.5% |
| Interest Expense | $169K | -9.6% |
| Pre-tax Income | -$9.3M | -44.4% |
| Income Tax | $388K |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.3M | +282.0% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $12.7M | -13.5% |
| Inventory | $30.9M | +17.8% |
| Current Assets | $88.5M | -1.0% |
| Total Assets | $153.0M | +0.6% |
| Current Liabilities | $24.4M | +42.1% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.2M | -144.8% |
| Capital Expenditures | $8.0M | +106.7% |
| Investing Cash Flow | $42.7M | +1016.4% |
| Financing Cash Flow | -$1.0M | +84.1% |
| Free Cash Flow | -$30.2M | -133.4% |
| +240.4% |
| Net Income | -$9.7M | -47.8% |
| EPS (Basic) | -$0.76 | -52.0% |
| EPS (Diluted) | -$0.76 | -52.0% |
| Long-term Debt |
| $0 |
| — |
| Total Liabilities | $27.5M | +56.7% |
| Stockholders' Equity | $125.5M | -6.8% |